Digital inhalers that measure and record inhalation data and that can remotely monitor patients may help predict impending chronic…
Articles by Steve Bryson, PhD
A digital, community-based intervention to treat chronic obstructive pulmonary disease (COPD) exacerbations in a home setting significantly improved the…
Dry-powder corticosteroid inhalers, or those designed to have a low impact on climate, are as effective as those based on…
Exposure to certain air pollution gases — pollutants called volatile organic compounds (VOCs), especially benzene and toluene — significantly increases…
Dupixent (dupilumab) as an add-on maintenance treatment significantly eased exacerbations and lung symptom severity while improving lung function and quality…
Travel times limit access to pulmonary rehabilitation programs to help people with chronic lung conditions, such as chronic obstructive…
Yupelri (revefenacin) is not superior to Spiriva (tiotropium) at improving lung function in adults with severe chronic…
Marpai, an artificial intelligence-powered administrator of employer health plans, is partnering with NuvoAir to provide virtual care for…
Nighttime breathing symptoms related to chronic obstructive pulmonary disease (COPD) significantly impaired daily activities and health-related quality of life,…
Nuance Pharma has been given the go-ahead to launch clinical trials in China to evaluate the investigational therapy ensifentrine…